Professor Gil is a Barbara S. Goodman Endowed Investigator (ICRF) and the Chairman, Department of Otolaryngology Head and Neck Surgery, Rambam Healthcare Campus, Israel Institute of Technology. Holding an MD and PhD in Biophysics and Neuroscience, he is Head of the Applied Cancer Research Laboratory and a member of the Rappaport Research Institute and the Clinical Research Institute at Rambam. He has received awards from the Israeli Parliament, NY Head and Neck Society, Israeli Cancer Society and Folks Foundation. The author of 3 books and over 200 scientific publications and book chapters, Dr Gil has established new techniques in skull base and robotic surgery. He serves on the Editorial Boards of multiple journals including Otolaryngology Head and Neck Surgery, Journal of Neurological Surgery, and Head and Neck. In 2014 he established the first comprehensive Head and Neck Center in Israel.Moran Amit, MD, PhD, completed his training in Head & Neck Surgery at the University of Texas MD Anderson Cancer Center, Houston, Texas, USA. His clinical focus is on robotic head and neck surgery and functional rehabilitation of head and neck cancer patients. Dr. Amit is a co-founder of the Adenoid Cystic Carcinoma International Study (AXIS) Group and a member of the International Consortium for Outcome Research (ICOR) in Head and Neck Cancer. Having published extensively on oral cavity, skull base and salivary gland cancer, he has received multiple AHNS and Israeli Cancer Society awards for his research on tumor immunology and resistance to treatment. Dr. Amit is a Barbara S. Goodman Endowed Investigator (ICRF). Dr. Michael Kupferman is an Associate Professor of Head & Neck Surgery at the University of Texas MD Anderson Cancer Center. He obtained his medical degree from the University of Pennsylvania School of Medicine and completed a residency at the Hospital of the University of Pennsylvania. After completing a two-year fellowship at MD Anderson Cancer Center (MDACC), he joined the faculty of the Department of Head and Neck Surgery, where he is an active member of the Skull Base Tumor Program. A respected expert in robotic surgery and in the management of thyroid cancer, Dr. Kupferman is also medical director of the Voice Center at MD Anderson. He also represents the MDACC across all national and international locations, making him responsible for evaluating surgical standards and practices and providing expertise in oncology across all disciplines.
